Energen (EGN) Misses Q2 EPS by 12c, Offers Guidance
Tweet
Share
E-mailGet Alerts EGN Hot Sheet
Join SI Premium – FREE
Energen (NYSE: EGN) reported Q2 EPS of $0.10, $0.12 worse than the analyst estimate of $0.22.
3Q15 AND CY15 FINANCIAL GUIDANCE
Energen’s estimated expenses, excluding San Juan Basin divestiture, are as follows:
| Per BOE, except where noted | 3Q15 | CY15 | ||||||||
| LOE (production costs, marketing & transportation) | $10.00- $10.65 | $9.25-$10.85 | ||||||||
| Production & ad valorem taxes (% of revenues, excluding hedges) | 7.8% | |||||||||
| DD&A expense | $24.50-$25.50 | $24.30-$25.80 | ||||||||
| General & administrative expense, net* | $5.25-$5.40 | $5.50-$5.85 | ||||||||
| Exploration expense (seismic, delay rentals, etc.) | $0.35-$0.45 | $0.40-$0.50 | ||||||||
| Interest expense ($MM) | $10.0-$10.5 | $40.0-$47.0 | ||||||||
* Excludes $0.07 per BOE in 3Q15 and $1.63 per BOE in CY15 for pension and pension settlement expenses. | ||||||||||
| | ||||||||||
For earnings history and earnings-related data on Energen (EGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
